Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Virol ; 77(3): 2182-94, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12525653

RESUMO

Cytomegalovirus (CMV) infections have been shown to dramatically affect solid organ transplant graft survival in both human and animal models. Recently, it was demonstrated that rat CMV (RCMV) infection accelerates the development of transplant vascular sclerosis (TVS) in both rat heart and small bowel graft transplants. However, the mechanisms involved in this process are still unclear. In the present study, we determined the kinetics of RCMV-accelerated TVS in a rat heart transplant model. Acute RCMV infection enhances the development of TVS in rat heart allografts, and this process is initiated between 21 and 24 days posttransplantation. The virus is consistently detected in the heart grafts from day 7 until day 35 posttransplantation but is rarely found at the time of graft rejection (day 45 posttransplantation). Grafts from RCMV-infected recipients had upregulation of chemokine expression compared to uninfected controls, and the timing of this increased expression paralleled that of RCMV-accelerated neointimal formation. In addition, graft vessels from RCMV-infected grafts demonstrate the increased infiltration of T cells and macrophages during periods of highest chemokine expression. These results suggest that CMV-induced acceleration of TVS involves the increased graft vascular infiltration of inflammatory cells through enhanced chemokine expression.


Assuntos
Quimiocinas/biossíntese , Citomegalovirus/patogenicidade , Rejeição de Enxerto/etiologia , Transplante de Coração/imunologia , Animais , Quimiocina CX3CL1 , Quimiocina CXCL10 , Quimiocinas C , Quimiocinas CX3C/biossíntese , Quimiocinas CXC/biossíntese , Doença Crônica , Interferon gama/biossíntese , Linfocinas/biossíntese , Masculino , Proteínas de Membrana/biossíntese , Ratos , Ratos Endogâmicos F344 , Sialoglicoproteínas/biossíntese , Linfócitos T/imunologia , Transplante Homólogo , Regulação para Cima
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...